422 related articles for article (PubMed ID: 22832525)
1. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
[TBL] [Abstract][Full Text] [Related]
2. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
3. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
[TBL] [Abstract][Full Text] [Related]
4. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito.
Fujitsuka N; Asakawa A; Amitani H; Hattori T; Inui A
Crit Rev Oncog; 2012; 17(3):277-84. PubMed ID: 22831158
[TBL] [Abstract][Full Text] [Related]
6. Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome.
Fujitsuka N; Uezono Y
Front Pharmacol; 2014; 5():271. PubMed ID: 25540621
[TBL] [Abstract][Full Text] [Related]
7. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
Fujitsuka N; Asakawa A; Hayashi M; Sameshima M; Amitani H; Kojima S; Fujimiya M; Inui A
Biol Psychiatry; 2009 May; 65(9):748-59. PubMed ID: 19058784
[TBL] [Abstract][Full Text] [Related]
9. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia.
Yakabi K; Sadakane C; Noguchi M; Ohno S; Ro S; Chinen K; Aoyama T; Sakurada T; Takabayashi H; Hattori T
Endocrinology; 2010 Aug; 151(8):3773-82. PubMed ID: 20534732
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
[TBL] [Abstract][Full Text] [Related]
11. Neurohormones, rikkunshito and hypothalamic neurons interactively control appetite and anorexia.
Yada T; Kohno D; Maejima Y; Sedbazar U; Arai T; Toriya M; Maekawa F; Kurita H; Niijima A; Yakabi K
Curr Pharm Des; 2012; 18(31):4854-64. PubMed ID: 22632865
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma ghrelin contributes to anorexia following novelty stress.
Saegusa Y; Takeda H; Muto S; Nakagawa K; Ohnishi S; Sadakane C; Nahata M; Hattori T; Asaka M
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E685-96. PubMed ID: 21712530
[TBL] [Abstract][Full Text] [Related]
13. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.
Wang W; Andersson M; Iresjö BM; Lönnroth C; Lundholm K
Int J Oncol; 2006 Jun; 28(6):1393-400. PubMed ID: 16685441
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.
Perboni S; Bowers C; Kojima S; Asakawa A; Inui A
World J Gastroenterol; 2008 Nov; 14(41):6303-5. PubMed ID: 19009643
[TBL] [Abstract][Full Text] [Related]
15. Rikkunshito as a ghrelin enhancer.
Takeda H; Muto S; Nakagawa K; Ohnishi S; Sadakane C; Saegusa Y; Nahata M; Hattori T; Asaka M
Methods Enzymol; 2012; 514():333-51. PubMed ID: 22975063
[TBL] [Abstract][Full Text] [Related]
16. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
[TBL] [Abstract][Full Text] [Related]
17. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
18. Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus.
Arai T; Maejima Y; Muroya S; Yada T
Neuropeptides; 2013 Aug; 47(4):225-30. PubMed ID: 23756052
[TBL] [Abstract][Full Text] [Related]
19. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition.
Takeda H; Muto S; Hattori T; Sadakane C; Tsuchiya K; Katsurada T; Ohkawara T; Oridate N; Asaka M
Endocrinology; 2010 Jan; 151(1):244-52. PubMed ID: 19906817
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
